2238 Lu, Bo - Thomas Jefferson University - Thomas Jefferson University

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect
  2. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  3. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
  4. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma
  5. ALK inhibitor PF02341066 (Crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
  6. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects
  7. Molecular profiling to optimize treatment in non-small cell lung cancer: A review of potential molecular targets for radiation therapy by the translational research program of the Radiation Therapy Oncology Group
  8. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer
  9. Heat shock protein 90 inhibition: Rationale and clinical potential
  10. Occult nodal metastasis in non-small-cell lung cancer: Implications for the radiation oncologist
  11. Guidelines for the use and interpretation of assays for monitoring autophagy
  12. The Aurora Kinase A polymorphisms are not associated with recurrencefree survival in prostate cancer patients
  13. Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells
  14. Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation
  15. BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro
  16. An approach for online evaluations of dose consequences 07E7 caused by small rotational setup errors in intracranial stereotactic radiation therapy
  17. A novel bioluminescence orthotopic mouse model for advanced lung cancer
  18. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death
  19. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase
  20. MLN8054, A small molecule inhibitor of Aurora kinase A, sensitizes androgen-resistant prostate cancer to radiation